T1	Participants 50 81	patients with advanced melanoma
T2	Participants 640 671	patients with advanced melanoma
T3	Participants 694 766	From January 2000 to April 2002, 132 patients were enrolled on the study
T4	Participants 843 890	Patients with cerebral metastases were included
